The effect of topical application of tranexamic acid on postoperative bleeding and wound effusions in patients undergoing tangential skin excision - topical tranexamic acid in superficial skin wounds

Department of Surgery, St Olav's University Hospital0 个研究点目标入组 20 人开始时间: 2016年6月21日最近更新: 2020年2月1日

试验速览

暂无简介。

•Patients above 18 years of age to undergo split skin graft harvesting and hence getting a tangential superficial wound at the donor site, or patients who are to undergo tangential excisional revision of superficial wounds.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 15
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 5

•Patients who may be pregnant or who are nursing are not eligible for the study. Patients will receive a very low dose with tranexamic acid, of which a fraction can be expected to be absorbed systemically. As large studies have not found any increased risk of thromboembolic events or other adverse events from administering larger doses of tranexamic acid intravenously, we do not have any exclusion criteria for participation in the study due to fear of adverse effects.
•Patients who are known to be allergic to tranexamic acid will be excluded from the study.

发起方

Department of Surgery, St Olav's University Hospital